Cargando…

Complications and Management of the Thoracic Endovascular Aortic Repair

Endovascular treatment in thoracic aortic diseases has increased in use exponentially since Dake and colleagues first described the use of a home-made transluminal endovascular graft on 13 patients with descending thoracic aortic aneurysm at Stanford University in the early 1990s. Thoracic endovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sheena W., Lee, Kyongjune B., Napolitano, Michael A., Murillo-Berlioz, Alejandro E., Sattah, Anna P., Sarin, Shawn, Trachiotis, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644296/
https://www.ncbi.nlm.nih.gov/pubmed/33152785
http://dx.doi.org/10.1055/s-0040-1714089
_version_ 1783606424295702528
author Chen, Sheena W.
Lee, Kyongjune B.
Napolitano, Michael A.
Murillo-Berlioz, Alejandro E.
Sattah, Anna P.
Sarin, Shawn
Trachiotis, Gregory
author_facet Chen, Sheena W.
Lee, Kyongjune B.
Napolitano, Michael A.
Murillo-Berlioz, Alejandro E.
Sattah, Anna P.
Sarin, Shawn
Trachiotis, Gregory
author_sort Chen, Sheena W.
collection PubMed
description Endovascular treatment in thoracic aortic diseases has increased in use exponentially since Dake and colleagues first described the use of a home-made transluminal endovascular graft on 13 patients with descending thoracic aortic aneurysm at Stanford University in the early 1990s. Thoracic endovascular aneurysm repair (TEVAR) was initially developed for therapy in patients deemed unfit for open surgery. Innovations in endograft engineering design and popularization of endovascular techniques have transformed TEVAR to the predominant treatment choice in elective thoracic aortic repair. The number of TEVARs performed in the United States increased by 600% from 1998 to 2007, while the total number of thoracic aortic repairs increased by 60%. As larger multicenter trials and meta-analysis studies in the 2000s demonstrate the significant decrease in perioperative morbidity and mortality of TEVAR over open repair, TEVAR became incorporated into standard guidelines. The 2010 American consensus guidelines recommend TEVAR to be “strongly considered” when feasible for patients with degenerative or traumatic aneurysms of the descending thoracic aorta exceeding 5.5 cm, saccular aneurysms, or postoperative pseudoaneurysms. Nowadays, TEVAR is the predominant treatment for degenerative and traumatic descending thoracic aortic aneurysm repair. Although TEVAR has been shown to have decreased early morbidity and mortality compared with open surgical repair, endovascular manipulation of a diseased aorta with endovascular devices continues to have significant risks. Despite continued advancement in endovascular technique and devices since the first prospective trial examined the complications associated with TEVAR, common complications, two decades later, still include stroke, spinal cord ischemia, device failure, unintentional great vessel coverage, access site complications, and renal injury. In this article, we review common TEVAR complications with some corresponding radiographic imaging and their management.
format Online
Article
Text
id pubmed-7644296
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-76442962020-11-09 Complications and Management of the Thoracic Endovascular Aortic Repair Chen, Sheena W. Lee, Kyongjune B. Napolitano, Michael A. Murillo-Berlioz, Alejandro E. Sattah, Anna P. Sarin, Shawn Trachiotis, Gregory Aorta (Stamford) Endovascular treatment in thoracic aortic diseases has increased in use exponentially since Dake and colleagues first described the use of a home-made transluminal endovascular graft on 13 patients with descending thoracic aortic aneurysm at Stanford University in the early 1990s. Thoracic endovascular aneurysm repair (TEVAR) was initially developed for therapy in patients deemed unfit for open surgery. Innovations in endograft engineering design and popularization of endovascular techniques have transformed TEVAR to the predominant treatment choice in elective thoracic aortic repair. The number of TEVARs performed in the United States increased by 600% from 1998 to 2007, while the total number of thoracic aortic repairs increased by 60%. As larger multicenter trials and meta-analysis studies in the 2000s demonstrate the significant decrease in perioperative morbidity and mortality of TEVAR over open repair, TEVAR became incorporated into standard guidelines. The 2010 American consensus guidelines recommend TEVAR to be “strongly considered” when feasible for patients with degenerative or traumatic aneurysms of the descending thoracic aorta exceeding 5.5 cm, saccular aneurysms, or postoperative pseudoaneurysms. Nowadays, TEVAR is the predominant treatment for degenerative and traumatic descending thoracic aortic aneurysm repair. Although TEVAR has been shown to have decreased early morbidity and mortality compared with open surgical repair, endovascular manipulation of a diseased aorta with endovascular devices continues to have significant risks. Despite continued advancement in endovascular technique and devices since the first prospective trial examined the complications associated with TEVAR, common complications, two decades later, still include stroke, spinal cord ischemia, device failure, unintentional great vessel coverage, access site complications, and renal injury. In this article, we review common TEVAR complications with some corresponding radiographic imaging and their management. Thieme Medical Publishers 2020-11-05 /pmc/articles/PMC7644296/ /pubmed/33152785 http://dx.doi.org/10.1055/s-0040-1714089 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ). https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Chen, Sheena W.
Lee, Kyongjune B.
Napolitano, Michael A.
Murillo-Berlioz, Alejandro E.
Sattah, Anna P.
Sarin, Shawn
Trachiotis, Gregory
Complications and Management of the Thoracic Endovascular Aortic Repair
title Complications and Management of the Thoracic Endovascular Aortic Repair
title_full Complications and Management of the Thoracic Endovascular Aortic Repair
title_fullStr Complications and Management of the Thoracic Endovascular Aortic Repair
title_full_unstemmed Complications and Management of the Thoracic Endovascular Aortic Repair
title_short Complications and Management of the Thoracic Endovascular Aortic Repair
title_sort complications and management of the thoracic endovascular aortic repair
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644296/
https://www.ncbi.nlm.nih.gov/pubmed/33152785
http://dx.doi.org/10.1055/s-0040-1714089
work_keys_str_mv AT chensheenaw complicationsandmanagementofthethoracicendovascularaorticrepair
AT leekyongjuneb complicationsandmanagementofthethoracicendovascularaorticrepair
AT napolitanomichaela complicationsandmanagementofthethoracicendovascularaorticrepair
AT murilloberliozalejandroe complicationsandmanagementofthethoracicendovascularaorticrepair
AT sattahannap complicationsandmanagementofthethoracicendovascularaorticrepair
AT sarinshawn complicationsandmanagementofthethoracicendovascularaorticrepair
AT trachiotisgregory complicationsandmanagementofthethoracicendovascularaorticrepair